0001567619-22-019133.txt : 20221103
0001567619-22-019133.hdr.sgml : 20221103
20221103172007
ACCESSION NUMBER: 0001567619-22-019133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221101
FILED AS OF DATE: 20221103
DATE AS OF CHANGE: 20221103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tyagarajan N. V.
CENTRAL INDEX KEY: 0001408239
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33626
FILM NUMBER: 221359173
MAIL ADDRESS:
STREET 1: 825 EIGHTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Genpact LTD
CENTRAL INDEX KEY: 0001398659
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 980533350
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CANON'S COURT
STREET 2: 22 VICTORIA STREET
CITY: HAMILTON
STATE: D0
ZIP: HM 12
BUSINESS PHONE: 4412952244
MAIL ADDRESS:
STREET 1: CANON'S COURT
STREET 2: 22 VICTORIA STREET
CITY: HAMILTON
STATE: D0
ZIP: HM 12
4
1
doc1.xml
FORM 4
X0306
4
2022-11-01
0
0001398659
Genpact LTD
G
0001408239
Tyagarajan N. V.
C/O GENPACT LLC
1155 AVENUE OF THE AMERICAS, 4TH FLOOR
NEW YORK
NY
10036
1
1
0
0
President and CEO
Common Shares
2022-11-01
4
M
0
50000
19.35
A
694377
D
Common Shares
2022-11-01
4
S
0
50000
48.4573
D
644377
D
Common Shares
2022-11-02
4
M
0
50000
19.35
A
694377
D
Common Shares
2022-11-02
4
S
0
42959
48.1906
D
651418
D
Common Shares
2022-11-02
4
S
0
7041
48.5447
D
644377
D
Common Shares
2022-11-03
4
M
0
50000
19.35
A
694377
D
Common Shares
2022-11-03
4
S
0
49974
46.5137
D
644403
D
Common Shares
2022-11-03
4
S
0
26
47.245
D
644377
D
Common Shares
10000
I
By Trust
Employee Stock Option (Right to Buy)
19.35
2022-11-01
4
M
0
50000
0
D
2023-05-30
Common Shares
50000
1300000
D
Employee Stock Option (Right to Buy)
19.35
2022-11-02
4
M
0
50000
0
D
2023-05-30
Common Shares
50000
1250000
D
Employee Stock Option (Right to Buy)
19.35
2022-11-03
4
M
0
50000
0
D
2023-05-30
Common Shares
50000
1200000
D
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $48.10 to $48.793. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.46 to $48.455. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $48.46 to $48.84. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.14 to $47.09. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
The option vested 50% on January 10, 2016 and the remainder on January 10, 2018.
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
/s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan
2022-11-03